Skip to main content
Top
Published in: Respiratory Research 1/2010

Open Access 01-12-2010 | Research

The TGF-beta-Pseudoreceptor BAMBI is strongly expressed in COPD lungs and regulated by nontypeable Haemophilus influenzae

Authors: Daniel Drömann, Jan Rupp, Kristina Rohmann, Sinia Osbahr, Artur J Ulmer, Sebastian Marwitz, Kristina Röschmann, Mahdi Abdullah, Holger Schultz, Ekkehard Vollmer, Peter Zabel, Klaus Dalhoff, Torsten Goldmann

Published in: Respiratory Research | Issue 1/2010

Login to get access

Abstract

Background

Nontypeable Haemophilus influenzae (NTHI) may play a role as an infectious trigger in the pathogenesis of chronic obstructive pulmonary disease (COPD). Few data are available regarding the influence of acute and persistent infection on tissue remodelling and repair factors such as transforming growth factor (TGF)-β.

Methods

NTHI infection in lung tissues obtained from COPD patients and controls was studied in vivo and using an in vitro model. Infection experiments were performed with two different clinical isolates. Detection of NTHI was done using in situ hybridization (ISH) in unstimulated and in in vitro infected lung tissue. For characterization of TGF-β signaling molecules a transcriptome array was performed. Expression of the TGF-pseudoreceptor BMP and Activin Membrane-bound Inhibitor (BAMBI) was analyzed using immunohistochemistry (IHC), ISH and PCR. CXC chemokine ligand (CXCL)-8, tumor necrosis factor (TNF)-α and TGF-β expression were evaluated in lung tissue and cell culture using ELISA.

Results

In 38% of COPD patients infection with NTHI was detected in vivo in contrast to 0% of controls (p < 0.05). Transcriptome arrays showed no significant changes of TGF-β receptors 1 and 2 and Smad-3 expression, whereas a strong expression of BAMBI with upregulation after in vitro infection of COPD lung tissue was demonstrated. BAMBI was expressed ubiquitously on alveolar macrophages (AM) and to a lesser degree on alveolar epithelial cells (AEC). Measurement of cytokine concentrations in lung tissue supernatants revealed a decreased expression of TGF-β (p < 0.05) in combination with a strong proinflammatory response (p < 0.01).

Conclusions

We show for the first time the expression of the TGF pseudoreceptor BAMBI in the human lung, which is upregulated in response to NTHI infection in COPD lung tissue in vivo and in vitro. The combination of NTHI-mediated induction of proinflammatory cytokines and inhibition of TGF-β expression may influence inflammation induced tissue remodeling.
Literature
1.
go back to reference Sethi S, Muscarella K, Evans N, Klingman KL, Grant BJ, Murphy TF: Airway inflammation and etiology of acute exacerbations of chronic bronchitis. Chest 2000,118(6):1557–1565.CrossRefPubMed Sethi S, Muscarella K, Evans N, Klingman KL, Grant BJ, Murphy TF: Airway inflammation and etiology of acute exacerbations of chronic bronchitis. Chest 2000,118(6):1557–1565.CrossRefPubMed
2.
go back to reference Sethi S, Evans N, Grant BJ, Murphy TF: New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med 2002,347(7):465–471.CrossRefPubMed Sethi S, Evans N, Grant BJ, Murphy TF: New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med 2002,347(7):465–471.CrossRefPubMed
3.
go back to reference Sethi S, Sethi R, Eschberger K, Lobbins P, Cai X, Grant BJ, et al.: Airway bacterial concentrations and exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007,176(4):356–361.CrossRefPubMed Sethi S, Sethi R, Eschberger K, Lobbins P, Cai X, Grant BJ, et al.: Airway bacterial concentrations and exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007,176(4):356–361.CrossRefPubMed
4.
5.
go back to reference Abusriwil H, Stockley RA: The interaction of host and pathogen factors in chronic obstructive pulmonary disease exacerbations and their role in tissue damage. Proc Am Thorac Soc 2007,4(8):611–617.CrossRefPubMed Abusriwil H, Stockley RA: The interaction of host and pathogen factors in chronic obstructive pulmonary disease exacerbations and their role in tissue damage. Proc Am Thorac Soc 2007,4(8):611–617.CrossRefPubMed
6.
go back to reference Gauldie J, Kolb M, Ask K, Martin G, Bonniaud P, Warburton D: Smad3 signaling involved in pulmonary fibrosis and emphysema. Proc Am Thorac Soc 2006,3(8):696–702.CrossRefPubMedPubMedCentral Gauldie J, Kolb M, Ask K, Martin G, Bonniaud P, Warburton D: Smad3 signaling involved in pulmonary fibrosis and emphysema. Proc Am Thorac Soc 2006,3(8):696–702.CrossRefPubMedPubMedCentral
7.
go back to reference Cuzzocrea S, Genovese T, Failla M, Vecchio G, Fruciano M, Mazzon E, et al.: Protective effect of orally administered carnosine on bleomycin-induced lung injury. Am J Physiol Lung Cell Mol Physiol 2007,292(5):L1095-L1104.CrossRefPubMed Cuzzocrea S, Genovese T, Failla M, Vecchio G, Fruciano M, Mazzon E, et al.: Protective effect of orally administered carnosine on bleomycin-induced lung injury. Am J Physiol Lung Cell Mol Physiol 2007,292(5):L1095-L1104.CrossRefPubMed
8.
go back to reference Letterio JJ, Roberts AB: Regulation of immune responses by TGF-beta. Annu Rev Immunol 1998, 16:137–161.CrossRefPubMed Letterio JJ, Roberts AB: Regulation of immune responses by TGF-beta. Annu Rev Immunol 1998, 16:137–161.CrossRefPubMed
9.
go back to reference Zhang X, Giangreco L, Broome HE, Dargan CM, Swain SL: Control of CD4 effector fate: transforming growth factor beta 1 and interleukin 2 synergize to prevent apoptosis and promote effector expansion. J Exp Med 1995,182(3):699–709.CrossRefPubMed Zhang X, Giangreco L, Broome HE, Dargan CM, Swain SL: Control of CD4 effector fate: transforming growth factor beta 1 and interleukin 2 synergize to prevent apoptosis and promote effector expansion. J Exp Med 1995,182(3):699–709.CrossRefPubMed
10.
go back to reference Chen J, Bush JO, Ovitt CE, Lan Y, Jiang R: The TGF-beta pseudoreceptor gene Bambi is dispensable for mouse embryonic development and postnatal survival. Genesis 2007,45(8):482–486.CrossRefPubMedPubMedCentral Chen J, Bush JO, Ovitt CE, Lan Y, Jiang R: The TGF-beta pseudoreceptor gene Bambi is dispensable for mouse embryonic development and postnatal survival. Genesis 2007,45(8):482–486.CrossRefPubMedPubMedCentral
11.
go back to reference Sekiya T, Oda T, Matsuura K, Akiyama T: Transcriptional regulation of the TGF-beta pseudoreceptor BAMBI by TGF-beta signaling. Biochem Biophys Res Commun 2004,320(3):680–684.CrossRefPubMed Sekiya T, Oda T, Matsuura K, Akiyama T: Transcriptional regulation of the TGF-beta pseudoreceptor BAMBI by TGF-beta signaling. Biochem Biophys Res Commun 2004,320(3):680–684.CrossRefPubMed
12.
go back to reference Onichtchouk D, Chen YG, Dosch R, Gawantka V, Delius H, Massague J, et al.: Silencing of TGF-beta signalling by the pseudoreceptor BAMBI. Nature 1999,401(6752):480–485.CrossRefPubMed Onichtchouk D, Chen YG, Dosch R, Gawantka V, Delius H, Massague J, et al.: Silencing of TGF-beta signalling by the pseudoreceptor BAMBI. Nature 1999,401(6752):480–485.CrossRefPubMed
13.
go back to reference Seki E, De Minicis S, Osterreicher CH, Kluwe J, Osawa Y, Brenner DA, et al.: TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med 2007,13(11):1324–1332.CrossRefPubMed Seki E, De Minicis S, Osterreicher CH, Kluwe J, Osawa Y, Brenner DA, et al.: TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med 2007,13(11):1324–1332.CrossRefPubMed
14.
go back to reference Droemann D, Rupp J, Goldmann T, Uhlig U, Branscheid D, Vollmer E, et al.: Disparate innate immune responses to persistent and acute Chlamydia pneumoniae infection in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007,175(8):791–797.CrossRefPubMed Droemann D, Rupp J, Goldmann T, Uhlig U, Branscheid D, Vollmer E, et al.: Disparate innate immune responses to persistent and acute Chlamydia pneumoniae infection in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007,175(8):791–797.CrossRefPubMed
15.
go back to reference Rupp J, Droemann D, Goldmann T, Zabel P, Solbach W, Vollmer E, et al.: Alveolar epithelial cells type II are major target cells for C. pneumoniae in chronic but not in acute respiratory infection. FEMS Immunol Med Microbiol 2004,41(3):197–203.CrossRefPubMed Rupp J, Droemann D, Goldmann T, Zabel P, Solbach W, Vollmer E, et al.: Alveolar epithelial cells type II are major target cells for C. pneumoniae in chronic but not in acute respiratory infection. FEMS Immunol Med Microbiol 2004,41(3):197–203.CrossRefPubMed
16.
go back to reference Olert J, Wiedorn KH, Goldmann T, Kuhl H, Mehraein Y, Scherthan H, et al.: HOPE fixation: a novel fixing method and paraffin-embedding technique for human soft tissues. Pathol Res Pract 2001,197(12):823–826.CrossRefPubMed Olert J, Wiedorn KH, Goldmann T, Kuhl H, Mehraein Y, Scherthan H, et al.: HOPE fixation: a novel fixing method and paraffin-embedding technique for human soft tissues. Pathol Res Pract 2001,197(12):823–826.CrossRefPubMed
17.
go back to reference Droemann D, Goldmann T, Branscheid D, Clark R, Dalhoff K, Zabel P, et al.: Toll-like receptor 2 is expressed by alveolar epithelial cells type II and macrophages in the human lung. Histochem Cell Biol 2003,119(2):103–108.PubMed Droemann D, Goldmann T, Branscheid D, Clark R, Dalhoff K, Zabel P, et al.: Toll-like receptor 2 is expressed by alveolar epithelial cells type II and macrophages in the human lung. Histochem Cell Biol 2003,119(2):103–108.PubMed
18.
go back to reference Dakhova O, Ozen M, Creighton CJ, Li R, Ayala G, Rowley D, et al.: Global gene expression analysis of reactive stroma in prostate cancer. Clin Cancer Res 2009,15(12):3979–3989.CrossRefPubMedPubMedCentral Dakhova O, Ozen M, Creighton CJ, Li R, Ayala G, Rowley D, et al.: Global gene expression analysis of reactive stroma in prostate cancer. Clin Cancer Res 2009,15(12):3979–3989.CrossRefPubMedPubMedCentral
19.
go back to reference Schultz H, Kahler D, Branscheid D, Vollmer E, Zabel P, Goldmann T: TKTL1 is overexpressed in a large portion of non-small cell lung cancer specimens. Diagn Pathol 2008, 3:35.CrossRefPubMedPubMedCentral Schultz H, Kahler D, Branscheid D, Vollmer E, Zabel P, Goldmann T: TKTL1 is overexpressed in a large portion of non-small cell lung cancer specimens. Diagn Pathol 2008, 3:35.CrossRefPubMedPubMedCentral
20.
go back to reference Droemann D, Goldmann T, Tiedje T, Zabel P, Dalhoff K, Schaaf B: Toll-like receptor 2 expression is decreased on alveolar macrophages in cigarette smokers and COPD patients. Respir Res 2005, 6:68.CrossRefPubMedPubMedCentral Droemann D, Goldmann T, Tiedje T, Zabel P, Dalhoff K, Schaaf B: Toll-like receptor 2 expression is decreased on alveolar macrophages in cigarette smokers and COPD patients. Respir Res 2005, 6:68.CrossRefPubMedPubMedCentral
21.
go back to reference Bonniaud P, Kolb M, Galt T, Robertson J, Robbins C, Stampfli M, et al.: Smad3 null mice develop airspace enlargement and are resistant to TGF-beta-mediated pulmonary fibrosis. J Immunol 2004,173(3):2099–2108.CrossRefPubMed Bonniaud P, Kolb M, Galt T, Robertson J, Robbins C, Stampfli M, et al.: Smad3 null mice develop airspace enlargement and are resistant to TGF-beta-mediated pulmonary fibrosis. J Immunol 2004,173(3):2099–2108.CrossRefPubMed
22.
go back to reference Hyytiainen M, Penttinen C, Keski-Oja J: Latent TGF-beta binding proteins: extracellular matrix association and roles in TGF-beta activation. Crit Rev Clin Lab Sci 2004,41(3):233–264.CrossRefPubMed Hyytiainen M, Penttinen C, Keski-Oja J: Latent TGF-beta binding proteins: extracellular matrix association and roles in TGF-beta activation. Crit Rev Clin Lab Sci 2004,41(3):233–264.CrossRefPubMed
23.
go back to reference Lee CG, Kang HR, Homer RJ, Chupp G, Elias JA: Transgenic modeling of transforming growth factor-beta(1): role of apoptosis in fibrosis and alveolar remodeling. Proc Am Thorac Soc 2006,3(5):418–423.CrossRefPubMedPubMedCentral Lee CG, Kang HR, Homer RJ, Chupp G, Elias JA: Transgenic modeling of transforming growth factor-beta(1): role of apoptosis in fibrosis and alveolar remodeling. Proc Am Thorac Soc 2006,3(5):418–423.CrossRefPubMedPubMedCentral
24.
go back to reference Sheppard D: Transforming growth factor beta: a central modulator of pulmonary and airway inflammation and fibrosis. Proc Am Thorac Soc 2006,3(5):413–417.CrossRefPubMedPubMedCentral Sheppard D: Transforming growth factor beta: a central modulator of pulmonary and airway inflammation and fibrosis. Proc Am Thorac Soc 2006,3(5):413–417.CrossRefPubMedPubMedCentral
25.
go back to reference Togo N, Ohwada S, Sakurai S, Toya H, Sakamoto I, Yamada T, et al.: Prognostic significance of BMP and activin membrane-bound inhibitor in colorectal cancer. World J Gastroenterol 2008,14(31):4880–4888.CrossRefPubMedPubMedCentral Togo N, Ohwada S, Sakurai S, Toya H, Sakamoto I, Yamada T, et al.: Prognostic significance of BMP and activin membrane-bound inhibitor in colorectal cancer. World J Gastroenterol 2008,14(31):4880–4888.CrossRefPubMedPubMedCentral
26.
go back to reference Churg A, Tai H, Coulthard T, Wang R, Wright JL: Cigarette smoke drives small airway remodeling by induction of growth factors in the airway wall. Am J Respir Crit Care Med 2006,174(12):1327–1334.CrossRefPubMed Churg A, Tai H, Coulthard T, Wang R, Wright JL: Cigarette smoke drives small airway remodeling by induction of growth factors in the airway wall. Am J Respir Crit Care Med 2006,174(12):1327–1334.CrossRefPubMed
27.
go back to reference Hasday JD, Bascom R, Costa JJ, Fitzgerald T, Dubin W: Bacterial endotoxin is an active component of cigarette smoke. Chest 1999,115(3):829–835.CrossRefPubMed Hasday JD, Bascom R, Costa JJ, Fitzgerald T, Dubin W: Bacterial endotoxin is an active component of cigarette smoke. Chest 1999,115(3):829–835.CrossRefPubMed
28.
go back to reference McCrea KA, Ensor JE, Nall K, Bleecker ER, Hasday JD: Altered cytokine regulation in the lungs of cigarette smokers. Am J Respir Crit Care Med 1994,150(3):696–703.CrossRefPubMed McCrea KA, Ensor JE, Nall K, Bleecker ER, Hasday JD: Altered cytokine regulation in the lungs of cigarette smokers. Am J Respir Crit Care Med 1994,150(3):696–703.CrossRefPubMed
29.
go back to reference Sethi S, Murphy TF: Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med 2008,359(22):2355–2365.CrossRefPubMed Sethi S, Murphy TF: Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med 2008,359(22):2355–2365.CrossRefPubMed
30.
go back to reference Moller LV, Timens W, van der BW, Kooi K, de Wever B, Dankert J, et al.: Haemophilus influenzae in lung explants of patients with end-stage pulmonary disease. Am J Respir Crit Care Med 1998,157(3 Pt 1):950–956.CrossRefPubMed Moller LV, Timens W, van der BW, Kooi K, de Wever B, Dankert J, et al.: Haemophilus influenzae in lung explants of patients with end-stage pulmonary disease. Am J Respir Crit Care Med 1998,157(3 Pt 1):950–956.CrossRefPubMed
31.
go back to reference Strieter RM: What differentiates normal lung repair and fibrosis? Inflammation, resolution of repair, and fibrosis. Proc Am Thorac Soc 2008,5(3):305–310.CrossRefPubMedPubMedCentral Strieter RM: What differentiates normal lung repair and fibrosis? Inflammation, resolution of repair, and fibrosis. Proc Am Thorac Soc 2008,5(3):305–310.CrossRefPubMedPubMedCentral
32.
go back to reference Barnes PJ: The cytokine network in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2009,41(6):631–638.CrossRefPubMed Barnes PJ: The cytokine network in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2009,41(6):631–638.CrossRefPubMed
Metadata
Title
The TGF-beta-Pseudoreceptor BAMBI is strongly expressed in COPD lungs and regulated by nontypeable Haemophilus influenzae
Authors
Daniel Drömann
Jan Rupp
Kristina Rohmann
Sinia Osbahr
Artur J Ulmer
Sebastian Marwitz
Kristina Röschmann
Mahdi Abdullah
Holger Schultz
Ekkehard Vollmer
Peter Zabel
Klaus Dalhoff
Torsten Goldmann
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2010
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/1465-9921-11-67

Other articles of this Issue 1/2010

Respiratory Research 1/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.